Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | INMD | LMRI |
|---|---|---|
| Price | $14.01 | $10.59 |
| Change today | ▲ 0.14% | ▼ 1.12% |
| Market cap | $806.19M | $1.02B |
| Return, 3 months | -6.7% | -13.1% |
| Return, year to date | -4.6% | -42.8% |
| Return, 1 year | -6.9% | – |
| P/E (TTM) | 11.6 | -36.6 |
| P/B | 1.3 | 1.7 |
| P/E percentile vs own 5y | 57th | 23rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | 0.0% | +5.1% |
| Net profit growth (YoY) | -36.2% | +138.0% |
| Gross margin | 76.5% | 14.9% |
| Operating margin | 18.5% | 1.4% |
| Net margin | 20.7% | -2.7% |
| Return on equity | 12.3% | -4.5% |
| Analyst target vs. price | +21.3% | +62.1% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 31 | 46 |
| 30-day volatility | 11.4% | 37.1% |
| Max drawdown, 1 year | -23.2% | -63.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
